This is a working overview of incretin, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-03 and is reviewed periodically as new material appears.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Modified synthetic peptide | 39-residue backbone with non-natural residues |
| Receptor targets | GIP and GLP-1 | Dual incretin receptor agonist |
| Approximate molecular mass | 4,813 Da | Calculated from the peptide sequence |
| Administration route | Subcutaneous injection | Weekly schedule in approved products |
| Albumin binding | Present | Mediated by a C20 fatty diacid side chain |
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Portal was singled out for praise by reviewers. Official Xbox Magazine admired its unique puzzle gameplay mechanics, stating that it was the first major advance in puzzle gaming "since Russians started dropping blocks", referring to Tetris. The Escapist's Ben "Yahtzee" Croshaw stated in his Zero Punctuation review that he could not think of any criticism for Portal, saying that it had "some of the funniest pitch-black humor [he had] ever heard in a game" and concluded that it is "absolutely sublime from start to finish." The PlayStation 3 version's critical review scores suffered because of the technical issues first uncovered by 1UP.com. While discussing the retail version on a podcast, 1UP.com staff members agreed that a significant number of the frame rate problems had been resolved, but not all of them. They concluded that the PlayStation 3 version was not quite as smooth as the Xbox 360 version and recommended that "if you own both [consoles], you should do the 360" version. Kotaku's Michael McWhertor echoed that recommendation, though stated that those who only have a PlayStation 3 should still consider The Orange Box. While frame rate issues were the main complaint, the PlayStation 3 version was also criticized for unreliable voice chat and excessive network delay or lag in Team Fortress 2, as well as long load times generally. It was, however, praised for featuring anti-aliasing and a quick-save feature, neither of which were present in the Xbox 360 version (but were present in the PC version).
Source water hydrogen isotope patterns: For example, lake systems are more sensitive to hydrologic cycles than marine environments. Differential fractionation for various organisms and metabolic pathways: differences in organic composition can also reflect in primary signal. Isotopic exchange, H loss and H addition: This can involve mixing water-derived D with the primary signal. Generation of bitumen, oil and gas: There's a fractionation between the product and kerogen. Research on the Australian basins showed that δD of lacustrine algal sourced kerogen with terrestrial contributions varies from −105‰ to −200‰, and δD of kerogen from near-coastal depositional environment has a narrower range, −75‰ to −120‰. The smaller span in DHRs of coastal kerogen is thought to reflect the relatively stable regional climate. Pedentchouk and his colleagues reported δD values of -70‰ to -120‰ in immature to low mature kerogen from early Cretaceous lacustrine sediments in West Africa. Coals are from type III kerogen mostly derived from land plants, which should have a primary D/H signal sensitive to local meteoric water. Reddings et al. analyzed coals of various origins and found them randomly scattered across the range of −90‰ to −170‰. Rigby et al. found D contents decrease from −70‰ to −100‰ with increasing maturity in coal from Bass Basin and attributed this to latter exchange with low D water. Smith et al. studied H isotopes of coal samples from Antarctica and Australia. They found a strong negative correlation between δD and inferred paleolatitude.
On February 22, Calvo Sotelo submitted his government program to the approval of the Congress of Deputies but did not reach the absolute majority, so the vote would have to be repeated the following day, and then a simple majority would be enough to obtain the investiture of the Chamber. The afternoon of the 23rd, when the second vote was being taken, a group of armed civil guards under the command of Lieutenant Colonel Antonio Tejero burst into the Chamber of the Congress of Deputies. At the same time, the Captain General of the 3rd Military Region, Jaime Milans del Bosch, declared a "state of war" in his demarcation to the cry of "Long live the King and long live Spain forever!", established a curfew, and ordered tanks to occupy the city of Valencia, seat of the captaincy general. Milans also contacted the rest of the Captain Generals so that they would second his initiative, alleging that he was waiting for the king's orders. Thus began a coup d'état that had been months in the making.The Crown, a symbol of permanence and unity of the Nation, shall not tolerate in any way actions or activities of individuals seeking to interrupt by force the democratic process determined by the Constitution approved by the Spanish people through a referendum. —Speech of King Juan Carlos I in the early morning of February 24.When the King heard of what was happening, he ordered all the Captain Generals to remain at their posts and not to take the troops to the streets, and Milans del Bosch to order the tanks and soldiers occupying Valencia to return to their barracks.
Sources: en.wikipedia.org
Alginic acid, also called algin, is a naturally occurring, edible polysaccharide found in brown algae. It is hydrophilic and forms a viscous gum when hydrated. When the alginic acid binds with sodium and calcium ions, the resulting salts are known as alginates. Its colour ranges from white to yellowish-brown. It is sold in filamentous, granular, and powdered forms. It is a significant component of the biofilms produced by the bacterium Pseudomonas aeruginosa, a major pathogen found in the lungs of some people who have cystic fibrosis. The biofilm and P. aeruginosa have a high resistance to antibiotics, but are susceptible to inhibition by macrophages. Alginate was discovered by the British chemical scientist E. C. C. Stanford in 1881, and he patented an extraction process for it in the same year. The alginate was extracted, in the original patent, by first soaking the algae in water or diluted acid. The resulting insoluble alginic acid is then treated with an alkaline solution such as sodium carbonate, creating sodium alginate, before finally precipitating and purifying the alginate from solution.
== Before Tiselius == Early work with the basic principle of electrophoresis dates to the early 19th century. The electrokinetic phenomenon was observed for the first time in 1807 by Russian professors Peter Ivanovich Strakhov and Ferdinand Frederic Reuß at Moscow University, who noticed that the application of a constant electric field caused clay particles dispersed in water to migrate. Experiments by Johann Wilhelm Hittorf, Walther Nernst, and Friedrich Kohlrausch to measure the properties and behavior of small ions moving through aqueous solutions under the influence of an electric field led to general mathematical descriptions of the electrochemistry of aqueous solutions. Kohlrausch created equations for varying concentrations of charged particles moving through solution, including sharp moving boundaries of migrating particles. By the beginning of the 20th century, electrochemists had found that such moving boundaries of charged particles could be created with U-shaped glass tubes. Methods of optical detection of moving boundaries in liquids had been developed by August Toepler in the 1860s; Toepler measured the schlieren (shadows) or slight variations in optical properties in inhomogeneous solutions. This method combined with the theoretical and experimental methods for creating and analysing charged moving boundaries would form the basis of Tiselius' moving-boundary electrophoresis method.
T4 (levothyroxine) is almost always preferred over T3 (liothyronine) when treating hypothyroidism. Treatment with T3 alone is not recommended, as it causes increased and potentially unsafe blood levels of free T3 (FT3). Combination treatment of hypothyroidism with T4 and T3 is generally only considered when treatment with T4 alone does not sufficiently resolve symptoms. As there is no evidence showing that combination treatment with T4 and T3 benefits patients, this approach is controversial, but it is supported by current guidelines of the European Thyroid Association and the British Thyroid Association for patients who do not respond at all to treatment with T4 alone.
Sources: en.wikipedia.org
== History == Menthol was first isolated in 1771, by the German, Hieronymus David Gaubius. Early characterizations were done by Oppenheim, Beckett, Moriya, and Atkinson. It was named by F. L. Alphonse Oppenheim (1833–1877) in 1861.
=== In vitro studies === In vitro studies have shown that omadacycline has activity against a broad range of Gram-positive and select Gram-negative pathogens. Omadacycline has potent in vitro activity against Gram-positive aerobic bacteria including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant and multi-drug resistant Streptococcus pneumoniae, and vancomycin-resistant Enterococcus. Omadacycline also has antimicrobial activity against common Gram-negative aerobes, some anaerobes, and atypical bacteria such as Legionella and Chlamydia. This activity translated to potent efficacy for omadacycline in an in vivo systemic infection model in mice. Additional in vitro and in vivo studies of omadacycline metabolism, disposition, and drug interactions show that omadacycline is metabolically stable (i.e., it does not undergo significant biotransformation) and neither inhibits nor interacts with metabolizing enzymes or transporters.
Commissioned by the Science Research Council and authored by Sir James Lighthill, the report provided a highly critical assessment of AI research, arguing that it had failed to achieve its "grandiose objectives". The report led to a severe reduction in government funding for AI in the UK, precipitating what is often referred to as the first "AI winter". In response to Japan's Fifth Generation Computer Systems initiative, the UK government launched the Alvey Programme in 1983. This five-year, £350 million collaborative R&D initiative aimed to revitalize the British IT sector, with a significant focus on Intelligent Knowledge Based Systems (IKBS), or expert systems. While the programme succeeded in fostering collaboration between academia and industry, it struggled to translate pre-competitive research into commercial success, leading to a second period of reduced funding and enthusiasm in the late 1980s and early 1990s. The modern era of UK AI research is characterised by significant breakthroughs in deep learning and reinforcement learning, commercialised by the London-based company DeepMind. Founded in 2010 by Demis Hassabis, Shane Legg, and Mustafa Suleyman, DeepMind achieved global recognition for its work on deep reinforcement learning. In 2015, they published a landmark paper in Nature demonstrating an AI agent capable of learning to play Atari 2600 games at a human level directly from sensory input. DeepMind's AlphaGo system subsequently made history in 2016 by defeating Lee Sedol, a world champion Go player, marking a major milestone in AI capabilities.
Sources: en.wikipedia.org
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.
A fatty diacid side chain promotes reversible binding to serum albumin. This association slows renal clearance and protects the peptide from rapid enzymatic degradation. The result is a prolonged circulation time that supports weekly administration.
The first regulatory approval, for type 2 diabetes, was granted in the United States in 2022. An additional approval for chronic weight management followed in 2023. Availability and approved indications vary by country and are set by each national regulator.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.